India will use its manufacturing capacity to make US vaccines, with financing coming from the US and JapanLeaders of the United States, India, Australia and Japan agreed to pool financing, manufacturing and distribution capacity to send 1 billion coronavirus vaccines across Asia by the end of 2022, India's foreign secretary said on Friday. The so-called "Quad" group of four nations want to expand global vaccinations and counter China's growing vaccination diplomacy in Southeast Asia and around the world. India is the world's biggest vaccine maker.
The collaboration was "most pressing and valuable", foreign secretary Harsh Vardhan Shringla told a news conference in India's capital New Delhi after the four-way virtual summit. "The four countries have agreed to a plan to pool their financial resources, manufacturing capabilities and capacities, and logistical strengths so as to ramp up the manufacturing and distribution of the COVID-19 vaccines in the Indo-Pacific region," he said. "We believe this will speed up the process of post-pandemic recovery and enable families and businesses to put the COVID-19 crisis behind them."